Pub. Date : 2018 Sep 3
PMID : 29855103
7 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | These magnetofluorescent BPQDs@DOX@ss-Fe3 O4 @C NPs were conjugated with a targeting aptamer (epidermal growth factor receptor: EGFR), denoted as BPQDs@DOX@ss-Fe3 O4 @C-EGFR NPs, for targeting dual modal magnetic resonance (MR)/fluorescence imaging. | Doxorubicin | epidermal growth factor receptor | Homo sapiens |
2 | These magnetofluorescent BPQDs@DOX@ss-Fe3 O4 @C NPs were conjugated with a targeting aptamer (epidermal growth factor receptor: EGFR), denoted as BPQDs@DOX@ss-Fe3 O4 @C-EGFR NPs, for targeting dual modal magnetic resonance (MR)/fluorescence imaging. | Doxorubicin | epidermal growth factor receptor | Homo sapiens |
3 | These magnetofluorescent BPQDs@DOX@ss-Fe3 O4 @C NPs were conjugated with a targeting aptamer (epidermal growth factor receptor: EGFR), denoted as BPQDs@DOX@ss-Fe3 O4 @C-EGFR NPs, for targeting dual modal magnetic resonance (MR)/fluorescence imaging. | Doxorubicin | epidermal growth factor receptor | Homo sapiens |
4 | These magnetofluorescent BPQDs@DOX@ss-Fe3 O4 @C NPs were conjugated with a targeting aptamer (epidermal growth factor receptor: EGFR), denoted as BPQDs@DOX@ss-Fe3 O4 @C-EGFR NPs, for targeting dual modal magnetic resonance (MR)/fluorescence imaging. | Doxorubicin | epidermal growth factor receptor | Homo sapiens |
5 | These magnetofluorescent BPQDs@DOX@ss-Fe3 O4 @C NPs were conjugated with a targeting aptamer (epidermal growth factor receptor: EGFR), denoted as BPQDs@DOX@ss-Fe3 O4 @C-EGFR NPs, for targeting dual modal magnetic resonance (MR)/fluorescence imaging. | Doxorubicin | epidermal growth factor receptor | Homo sapiens |
6 | These magnetofluorescent BPQDs@DOX@ss-Fe3 O4 @C NPs were conjugated with a targeting aptamer (epidermal growth factor receptor: EGFR), denoted as BPQDs@DOX@ss-Fe3 O4 @C-EGFR NPs, for targeting dual modal magnetic resonance (MR)/fluorescence imaging. | Doxorubicin | epidermal growth factor receptor | Homo sapiens |
7 | Thus, a theranostic system consisting of BPQDs@DOX@ss-Fe3 O4 @C-EGFR NPs is shown to generate excellent advantages in combined chemotherapy/photothermal therapy (PTT) with minimal side effects. | Doxorubicin | epidermal growth factor receptor | Homo sapiens |